MedPath

OTSUKA (PHILIPPINES) PHARMACEUTICAL, INC.

🇵🇭Philippines
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:4

Trial Phases

1 Phases

Phase 4:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 4
4 (100.0%)

"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"

Conditions
Major Depressive Disorder
Schizophrenia
Interventions
First Posted Date
2020-11-24
Last Posted Date
2020-12-01
Lead Sponsor
Otsuka Pharmaceutical, Inc., Philippines
Target Recruit Count
300
Registration Number
NCT04641780
Locations
🇵🇭

Otsuka (Philippines) Pharmaceutical Inc., Makati City, Metro Manila, Philippines

Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance

Completed
Conditions
Hyperlipidemia
First Posted Date
2016-04-06
Last Posted Date
2016-04-06
Lead Sponsor
Otsuka Pharmaceutical, Inc., Philippines
Target Recruit Count
3087
Registration Number
NCT02730390

Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room

Phase 4
Completed
Conditions
Asthma
Interventions
First Posted Date
2010-03-24
Last Posted Date
2010-03-24
Lead Sponsor
Otsuka Pharmaceutical, Inc., Philippines
Target Recruit Count
96
Registration Number
NCT01091337
Locations
🇵🇭

Philippine General Hospital, Manila, Philippines

Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines

Phase 4
Completed
Conditions
Polyneuropathy
Interventions
First Posted Date
2010-02-26
Last Posted Date
2010-02-26
Lead Sponsor
Otsuka Pharmaceutical, Inc., Philippines
Target Recruit Count
47
Registration Number
NCT01076478
Locations
🇵🇭

University of Santo Tomas Hospital, Manila, Philippines

Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy

Phase 4
Completed
Conditions
NSAID Induced Gastropathy
Interventions
First Posted Date
2008-03-21
Last Posted Date
2011-08-24
Lead Sponsor
Otsuka Pharmaceutical, Inc., Philippines
Target Recruit Count
30
Registration Number
NCT00641004
Locations
🇵🇭

University of Santo Tomas Hospital, Manila, Philippines

🇵🇭

Armed Forces of the Philippines Medical Center, Quezon City, Philippines

🇵🇭

Veterans Memorial Medical Center, Quezon City, Philippines

and more 1 locations
  • Prev
  • 1
  • 2
  • Next

News

India's Complex Regulatory Landscape Poses Major Hurdles for Pharmaceutical Approvals

India's fragmented regulatory system, split between Central and State bodies, creates significant challenges for pharmaceutical companies seeking drug approvals and consistent oversight.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.